Our latest article investigates the mainstreaming of hepatitis C care – a process known as ‘normalisation’ – and whether it can reduce the stigma and discrimination associated with the virus.
Our latest article considers how a ‘culture of human rights’ is defined in research into human rights charters across Australian jurisdictions, including the ACT.
In our latest article, we explore how alcohol and other drugs issues are considered in human rights scrutiny processes in Australian parliaments.
The law has the power to shape public understandings of hepatitis C infection, including how people with the virus understand themselves and their ability to avoid the stigma associated with it. The latest article from our project on the experiences of people treated for hepatitis C engages with the challenges posed by laws and policies devised in a pre-cure world.
Our new paper explores how this debate on roadside drug testing in the ACT unfolded.
We are excited to announce the publication of the first article from the ARC-funded project, ‘A world-first “post-human rights” framework for drug policy’. Co-authored by
Earlier in 2021, GLaD program researcher Emily Lenton led an article reporting on this work, titled ‘Upscaling HIV and hepatitis C testing in primary healthcare settings: Stigma-sensitive practice’ in the Australian Journal of Public Health.The article was co-authored with Jen Johnson, previously of the BBV Sector Development Program, and Dr Graham Brown. This article focuses on how healthcare settings can support the goal of upscaling HIV and hepatitis C testing in a way that delivers safe and stigma-free testing encounters.
We are excited to announce the publication of the first article from the project, ‘Addressing hepatitis C-related legal, policy and practice discrimination in a post-cure world’.